I like the PR too but I’d need assurance NP will follow through. I’m from the U.K. The last U.K. news never went anywhere and when NP was asked about it months later during one of the Q&As, he acted like the U.K. had never been in the conversation.

So is this maneuvering for FDA? Bait for BP? I hope so but more likely it was “we need to PR *something* to slow the drift downwards.”